Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and Cholangiocellular Carcinoma

3,4-dihydroxyphenylethanol has been researched along with Cholangiocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, X; Han, Z; Jiang, H; Li, S; Liu, L; Ma, Y; Pei, T; Song, R; Wang, J; Xu, D; Zheng, T	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylethanol and Cholangiocellular Carcinoma

Article	Year
Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study. Oncology reports, 2014, Volume: 31, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Extracellular Signal-Regulated MAP Kinases; Gallbladder Neoplasms; Humans; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phenylethyl Alcohol; Xenograft Model Antitumor Assays	2014

Article

Year

Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.

Oncology reports, 2014, Volume: 31, Issue:1

Topics: Animals; Antioxidants; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Extracellular Signal-Regulated MAP Kinases; Gallbladder Neoplasms; Humans; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phenylethyl Alcohol; Xenograft Model Antitumor Assays

2014